» Articles » PMID: 27052727

FGF Signaling in the Osteoprogenitor Lineage Non-autonomously Regulates Postnatal Chondrocyte Proliferation and Skeletal Growth

Overview
Journal Development
Specialty Biology
Date 2016 Apr 8
PMID 27052727
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

Fibroblast growth factor (FGF) signaling is important for skeletal development; however, cell-specific functions, redundancy and feedback mechanisms regulating bone growth are poorly understood. FGF receptors 1 and 2 (Fgfr1 and Fgfr2) are both expressed in the osteoprogenitor lineage. Double conditional knockout mice, in which both receptors were inactivated using an osteoprogenitor-specific Cre driver, appeared normal at birth; however, these mice showed severe postnatal growth defects that include an ∼50% reduction in body weight and bone mass, and impaired longitudinal bone growth. Histological analysis showed reduced cortical and trabecular bone, suggesting cell-autonomous functions of FGF signaling during postnatal bone formation. Surprisingly, the double conditional knockout mice also showed growth plate defects and an arrest in chondrocyte proliferation. We provide genetic evidence of a non-cell-autonomous feedback pathway regulating Fgf9, Fgf18 and Pthlh expression, which led to increased expression and signaling of Fgfr3 in growth plate chondrocytes and suppression of chondrocyte proliferation. These observations show that FGF signaling in the osteoprogenitor lineage is obligately coupled to chondrocyte proliferation and the regulation of longitudinal bone growth.

Citing Articles

Drug-Loaded Bioscaffolds for Osteochondral Regeneration.

Tong Y, Yuan J, Li Z, Deng C, Cheng Y Pharmaceutics. 2024; 16(8).

PMID: 39204440 PMC: 11360256. DOI: 10.3390/pharmaceutics16081095.


Review of published 467 achondroplasia patients: clinical and mutational spectrum.

Zhang X, Jiang S, Zhang R, Guo S, Sheng Q, Wang K Orphanet J Rare Dis. 2024; 19(1):29.

PMID: 38281003 PMC: 10822181. DOI: 10.1186/s13023-024-03031-1.


An FGFR2 mutation as the potential cause of a new phenotype including early-onset osteoporosis and bone fractures: a case report.

Dantsev I, Parfenenko M, Radzhabova G, Nikolaeva E BMC Med Genomics. 2023; 16(1):329.

PMID: 38098042 PMC: 10722747. DOI: 10.1186/s12920-023-01750-1.


Loss of Fgfr1 and Fgfr2 in Scleraxis-lineage cells leads to enlarged bone eminences and attachment cell death.

Wernle K, Sonnenfelt M, Leek C, Ganji E, Sullivan A, Offutt C Dev Dyn. 2023; 252(9):1180-1188.

PMID: 37212424 PMC: 10524747. DOI: 10.1002/dvdy.600.


Targeted deletion of Fgf9 in tendon disrupts mineralization of the developing enthesis.

Ganji E, Leek C, Duncan W, Patra D, Ornitz D, Killian M FASEB J. 2023; 37(3):e22777.

PMID: 36734881 PMC: 10108073. DOI: 10.1096/fj.202201614R.


References
1.
Ornitz D, Marie P . FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease. Genes Dev. 2002; 16(12):1446-65. DOI: 10.1101/gad.990702. View

2.
Chen J, Tu X, Esen E, Joeng K, Lin C, Arbeit J . WNT7B promotes bone formation in part through mTORC1. PLoS Genet. 2014; 10(1):e1004145. PMC: 3907335. DOI: 10.1371/journal.pgen.1004145. View

3.
Meyer M, Muller A, Yang J, Moik D, Ponzio G, Ornitz D . FGF receptors 1 and 2 are key regulators of keratinocyte migration in vitro and in wounded skin. J Cell Sci. 2012; 125(Pt 23):5690-701. PMC: 3575704. DOI: 10.1242/jcs.108167. View

4.
Hilton M, Tu X, Cook J, Hu H, Long F . Ihh controls cartilage development by antagonizing Gli3, but requires additional effectors to regulate osteoblast and vascular development. Development. 2005; 132(19):4339-51. DOI: 10.1242/dev.02025. View

5.
Kozhemyakina E, Lassar A, Zelzer E . A pathway to bone: signaling molecules and transcription factors involved in chondrocyte development and maturation. Development. 2015; 142(5):817-31. PMC: 4352987. DOI: 10.1242/dev.105536. View